For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Trump’s State of the Union: A closer look at the claims
Last night, President Trump delivered a State of the Union address filled with optimism, applause lines, and bold claims about the country’s direction. There…
Blog
FDA’s Moderna decision demonstrates how science and government are incompatible
Last week, the FDA announced that it would not be considering Moderna’s application for a new flu vaccine because the control group Moderna used…
Blog
Congress gets into the PBM business
In the recently passed appropriations bill, Congress enacted several Pharmacy Benefit Manager (PBM) reforms it has been contemplating for years. On the surface, these…
Search Posts
Op-Eds
Designer Jeans from Designer Genes: Henry Miller National Post Op-Ed
California Gov Published February 12, 2001 The National Post (Canada) Self-styled environmentalists have been virtually unanimous in opposing biotechnology,…
Op-Eds
FDA Fails to Give Olestra Fair Weight: Henry Miller LA Times Op-Ed
Published in the Los Angeles Times Published in the Los Angeles Times February 4, 2001 The sad…
Citation
Will Last-Minute Flood of FDA Rules Keep New Drugs, Foods off Market?
News Release
Thumbs Down On FDA Rules For Biotech Food
Washington, D.C. January 17, 2001 – The Competitive Enterprise Institute issued a strong condemnation of proposed new regulations for genetically-engineered foods released today…
News Release
Organic Food Standards May Violate First Amendment
WASHINGTON, DC December 20, 2000—New standards for organic foods may violate First Amendment free speech rights, the Competitive Enterprise…
News Release
FDA’s Pediatric Rule Challenged in Federal Lawsuit
A physicians’ association and two public interest groups today filed suit in federal court challenging the validity of the Food and Drug Administration’s “Pediatric Rule.”…